420 related articles for article (PubMed ID: 35646094)
1. Identification and Verification of Feature Biomarkers Associated With Immune Cells in Dilated Cardiomyopathy by Bioinformatics Analysis.
Zhu T; Wang M; Quan J; Du Z; Li Q; Xie Y; Lin M; Xu C; Xie Y
Front Genet; 2022; 13():874544. PubMed ID: 35646094
[No Abstract] [Full Text] [Related]
2. Bioinformatics prediction of potential mechanisms and biomarkers underlying dilated cardiomyopathy.
Liu Z; Song YN; Chen KY; Gao WL; Chen HJ; Liang GY
World J Cardiol; 2022 May; 14(5):282-296. PubMed ID: 35702326
[TBL] [Abstract][Full Text] [Related]
3. Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy.
Zhang H; Huo J; Jiang W; Shan Q
Mol Med Rep; 2020 Aug; 22(2):915-925. PubMed ID: 32626989
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis of immune cell infiltration patterns and potential diagnostic markers in atherosclerosis.
Ji H; Yuan L; Jiang W; Jiang Y; Jiang M; Sun X; Chen J
Sci Rep; 2023 Nov; 13(1):19821. PubMed ID: 37963970
[TBL] [Abstract][Full Text] [Related]
5. Exploring the pathogenesis and immune infiltration in dilated cardiomyopathy complicated with atrial fibrillation by bioinformatics analysis.
Gan T; Hu J; Aledan AKO; Liu W; Li C; Lu S; Wang Y; Xu Q; Wang Y; Wang Z
Front Immunol; 2023; 14():1049351. PubMed ID: 36733486
[TBL] [Abstract][Full Text] [Related]
6. Alterated gene expression in dilated cardiomyopathy after left ventricular assist device support by bioinformatics analysis.
Wei Y; Cao H; Peng YY; Zhang B
Front Cardiovasc Med; 2023; 10():1013057. PubMed ID: 37008310
[TBL] [Abstract][Full Text] [Related]
7. Six potential biomarkers in septic shock: a deep bioinformatics and prospective observational study.
Kong C; Zhu Y; Xie X; Wu J; Qian M
Front Immunol; 2023; 14():1184700. PubMed ID: 37359526
[TBL] [Abstract][Full Text] [Related]
8. Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis.
Bai J; Pu X; Zhang Y; Dai E
Ren Fail; 2022 Dec; 44(1):966-986. PubMed ID: 35713363
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics and Immune Infiltration Analyses Reveal the Key Pathway and Immune Cells in the Pathogenesis of Hypertrophic Cardiomyopathy.
Zhang XZ; Zhang S; Tang TT; Cheng X
Front Cardiovasc Med; 2021; 8():696321. PubMed ID: 34497835
[No Abstract] [Full Text] [Related]
10. Integrative analyses of potential biomarkers and pathways for non-obstructive azoospermia.
Zhong Y; Chen X; Zhao J; Deng H; Li X; Xie Z; Zhou B; Xian Z; Li X; Luo G; Li H
Front Genet; 2022; 13():988047. PubMed ID: 36506310
[No Abstract] [Full Text] [Related]
11. Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy.
Yang Y; Liu P; Teng R; Liu F; Zhang C; Lu X; Ding Y
Ann Transl Med; 2022 Mar; 10(6):348. PubMed ID: 35433958
[TBL] [Abstract][Full Text] [Related]
12. Identification of the Key Genes of Immune Infiltration in Dilated Cardiomyopathy.
Qi B; Wang HY; Ma X; Chi YF; Gui C
Int Heart J; 2023 Nov; 64(6):1054-1064. PubMed ID: 37967988
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression.
He B; Quan LP; Cai CY; Yu DY; Yan W; Wei QJ; Zhang Z; Huang XN; Liu L
Front Cardiovasc Med; 2022; 9():973279. PubMed ID: 36148059
[TBL] [Abstract][Full Text] [Related]
14. Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy.
Zhang Q; Fan M; Cao X; Geng H; Su Y; Wu C; Pan H; Pan M
Front Cardiovasc Med; 2022; 9():809470. PubMed ID: 35433865
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic biomarker candidates for pulpitis revealed by bioinformatics analysis of merged microarray gene expression datasets.
Chen M; Zeng J; Yang Y; Wu B
BMC Oral Health; 2020 Oct; 20(1):279. PubMed ID: 33046027
[TBL] [Abstract][Full Text] [Related]
16. Identification of hub biomarkers of myocardial infarction by single-cell sequencing, bioinformatics, and machine learning.
Zhang Q; Guo Y; Zhang B; Liu H; Peng Y; Wang D; Zhang D
Front Cardiovasc Med; 2022; 9():939972. PubMed ID: 35958412
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics Analysis and Identification of Genes and Pathways in Ischemic Cardiomyopathy.
Cao J; Liu Z; Liu J; Li C; Zhang G; Shi R
Int J Gen Med; 2021; 14():5927-5937. PubMed ID: 34584445
[TBL] [Abstract][Full Text] [Related]
18. Screening for immune-related biomarkers associated with myasthenia gravis and dilated cardiomyopathy based on bioinformatics analysis and machine learning.
Zhou G; Wang S; Lin L; Lu K; Lin Z; Zhang Z; Zhang Y; Cheng D; Szeto K; Peng R; Luo C
Heliyon; 2024 Apr; 10(7):e28446. PubMed ID: 38571624
[TBL] [Abstract][Full Text] [Related]
19. Identifying immune cell infiltration and diagnostic biomarkers in heart failure and osteoarthritis by bioinformatics analysis.
Wen B; Liu M; Qin X; Mao Z; Chen X
Medicine (Baltimore); 2023 Jun; 102(26):e34166. PubMed ID: 37390254
[TBL] [Abstract][Full Text] [Related]
20. Investigating possible dilated cardiomyopathy targets via bioinformatic analysis.
Zhou J; Wang X; Xiong W; Zhang M
Am J Transl Res; 2023; 15(7):4788-4795. PubMed ID: 37560246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
